Eli Lilly and Co has agreed to buy rights to an experimental compound for the treatment of various pains, including pain associated with osteoarthritis, from Glenmark Pharmaceuticals Ltd India. Lilly will pay a $45 million upfront fee as well as up to $215 million more in potential development and sales milestones, plus royalties. The compound, […]
WellPoint Inc. and Angie’s List are both racing to launch doctor-rating services early next year. But Angie’s List is already
sour over Well-Point’s decision to partner with New York-based Zagat Survey LLC for its doctor-rating service, apparently
without talking to Angie’s List.
Analysts and investors turned sour on Eli Lilly and Co.’s stock overnight after the Indianapolis drug maker stopped enrolling patients in two small safety trials of a potential blockbuster drug. Lilly shares opened today at $52.15, down $3.74 or 6.6 percent from their close yesterday. Lilly announced yesterday after markets closed that it had temporarily […]
Indianapolis-area companies are ponying up $1.15 million to help put on this month’s National FFA convention, an event expected to draw more than 55,000 members and their chaperones to the city. They’re backing the bigbudget affair largely because of the access it gives them to future leaders-from tomorrow’s policymakers to those who could someday work at these local firms. And the city is putting on quite a show to get the attention of the roughly 46,000 12-to 21-year-old members and…
Eli Lilly and Co. today said it would plow ahead with plans to develop an inhaled insulin product even as competitor Pfizer Inc. announced it would stop making its poor-selling Exubera version. Lilly President and Chief Operating Officer made the comment while discussing the Indianapolis drugmaker’s third-quarter results. Profit was up 6 percent, to $926.3 […]
If you look at stock market returns over a 100-year-plus time frame, the highestreturning industries have been pharmaceuticals and cosmetics. Dropping the time frame down to the last 25 years shows a different picture, with technology taking the top spot. But with more than a century of momentum, drug companies can still attract interest. Using a quantitative screen that I run every week, I noticed that biotechnology stocks have been picking up steam lately. This surprised me because the big…
What began in 1994 as a six-room schoolhouse with 38 students has grown into a three-building campus with 602 pupils. The growth of the International School of Indiana, which welcomed a new headmaster this year, has been possible because of increased support from an expanding flock of businesses. They believe in its mission: to help attract scientists and executives from around the world to this community by providing a global education for their children. Before the school opened, recalled Eli…
Many analysts are recommending that investors hold off on buying stock in Novo Nordisk because rival Eli Lilly and Co. might encounter a smash hit with a version of its Byetta diabetes treatment that would be taken only once a week. Nineteen of the 34 analysts who follow the Danish insulin maker have “hold” or […]
Shares of Targanta Therapeutics Inc. fell 7.5 percent yesterday in the company’s first day as a public company. The stock closed at $9.25 a share after opening at $10, the price sought in the $57 million initial public offering. Targanta is listed on NASDAQ under the ticker TARG. The Cambridge, Mass., firm is commercializing an […]
A local development team is working on a 10-story, mixed-use tribute to a man who helped design the original plan for Indianapolis,
Alexander Ralston. The $60 million project, dubbed Ralston Square, would feature a 150-room hotel, 55 condos, a 617-space
parking garage and 41,000 square feet of retail space.
Silicon Valley venture capitalist Jack Gill–and dozens like him–are being recruited from far beyond state lines to support Indiana’s incumbent governor. On Oct. 9, Gill will be in the crowd at technology entrepreneur Scott Jones’ Carmel mansion. Jones, who organized the event, aims to collect $1 million for Daniels in a single day.
When Shannon Linker went to work for the Arts Council of Indianapolis in mid-2002, it was a typical pass-through organization–re-granting
city money to local arts groups. Now Linker is director of an artist-services program for the council that is on par with
those offered in communities like Seattle and New York City but few other places.
Fairbanks Institute for Healthy Communities has given interim president Dr. Cynthia Helphingstine the permanent role. Locally based Fairbanks said today that Helphingstine also will be chief operating officer. Helphingstine has been vice president of business development at Inproteo LLC, an alliance among Eli Lilly and Co., Indiana and Purdue universities that develops life science technologies […]
Eli Lilly and Co. launched a three-year collaboration today with GE Global Research, the central research and development unit of New York-based General Electric Co. The companies will develop diagnostic tools to predict patients’ response to targeted cancer therapies. Lilly is in the testing phase for compounds that would aim chemotherapy at specific cancer cells; […]
The U.S. Supreme Court allowed Eli Lilly and Co. to keep its patent on its top-selling drug Zyprexa today by denying an appeal by two generic drug makers seeking to break the patent. Without comment, the court denied a request by units of Dr. Reddy’s Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. for the justices […]
Drug-coated stents, which are used to open clogged arteries, can be life savers-if they’re implanted correctly. The $6 billion global stent market has come under scrutiny lately from doctors and researchers concerned that poor technique by cardiologists may contribute to rare but dangerous blood clots that can form after a stent is inserted. Stents that aren’t placed properly over the affected area may enable clots to form. But a device developed by an IUPUI researcher could prevent mishaps by helping…
The pulse of Indiana’s fledgling life sciences sector will be taken later this month at an annual conference featuring some of the industry’s strongest advocates. Experts will weigh in on several topics ranging from the discovery of technology to accessing capital, which is a growing concern for the earliest-stage companies that are riskier investments. In its fourth year, the Indiana Life Sciences Forum will take place Oct. 22-23 at the Westin Indianapolis and will be hosted by Indiana business-development initiative…
Jerome Peribere has a 10-year plan to diversify Dow AgroSciences LLC, Indiana’s largest agricultural chemical company. Biotechnology is the blueprint. And through a series of aggressive international deals, Dow AgroSciences is building the framework for its future. By 2015, Peribere hopes to oversee a balanced portfolio of agricultural chemical and biotech products. “We’re in the stone age of biotechnology,” he said. “Tomorrow, it’s going to be used to create products we have no clue about.” Formed in 1989 as a…
Eli Lilly and Co. has agreed to pay $18 million to settle a bitter dispute it had with New York-based Emisphere Technologies Inc. Emisphere announced the settlement agreement this morning but gave no details. The agreement still needs approval from U.S. District Court Judge David Hamilton in Indianapolis. In January 2006, Hamilton ruled that Indianapolis-based […]
Fineline Printing Group in Indianapolis has spent $2.5 million on a Heidelberg Speedmaster printing press, an investment that will require hiring 25 more workers in the next two years, Fineline said yesterday. The German-built offset press is the most productive in its class, said Fineline, which is on the northwestside. Family-owned Fineline counts Eli Lilly […]
